Related Experiment Video
Updated: Oct 16, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Current perspectives on interventional treatment strategies in diabetic patients with coronary artery disease
1Cardiac Catheterization Laboratory and Cardiovascular Research Foundation, Washington Hospital Center, Washington, DC 20010, USA. rxk3@mhg.edu
Insights
Diabetes increases risks after heart procedures. Coronary artery bypass surgery may be better for diabetic patients with complex disease, while medication can improve outcomes for those undergoing stenting.
Area of Science:
- Cardiology
- Diabetology
- Vascular Medicine
Background:
- Diabetes mellitus significantly increases mortality and morbidity after coronary procedures.
- Diabetics experience higher rates of restenosis and accelerated atherosclerosis progression post-intervention.
- These factors complicate treatment decisions for multivessel coronary artery disease in diabetic patients.
Purpose of the Study:
- To explore mechanisms behind increased restenosis in diabetics.
- To evaluate clinical outcomes of diabetic patients after coronary interventions.
- To review treatment alternatives and the role of adjunctive pharmacotherapy in diabetic coronary artery disease.
Main Methods:
- Literature review of studies on diabetes and coronary interventions.
- Analysis of factors influencing restenosis and atherosclerosis.
- Examination of outcomes for percutaneous coronary interventions versus coronary artery bypass surgery.
- Assessment of pharmacotherapy's impact on diabetic patients.
Main Results:
- Diabetes is linked to higher restenosis rates and accelerated atherosclerosis.
- Surgical revascularization may be favored in complex diabetic multivessel disease.
- Adjunctive pharmacotherapy, including antiplatelets and statins, improves outcomes in diabetic patients undergoing PCI.
Conclusions:
- Diabetic patients present unique challenges in coronary revascularization.
- Treatment strategies must consider factors like restenosis and atherosclerosis burden.
- Optimizing pharmacotherapy is crucial for improving outcomes in diabetic patients undergoing PCI.
Abstract:
Diabetes mellitus has a negative impact on mortality and morbidity following catheter-based coronary procedures as well as coronary artery bypass surgery. Increased restenosis remains the main limitation of catheter-based coronary intervention among diabetes mellitus in addition to accelerated atherosclerosis lesion progression in other untreated coronary sites. Determinants such as excess restenosis, high atherosclerosis burden, lesion complexity, small target vessel size, and accelerated coronary atherosclerosis in remote sites may favor the surgical strategy in most cases of diabetic multivessel disease. The importance of periprocedural adjunctive pharmacotherapy, specifically with the use of antiplatelet and long-term antilipidemic treatment, was shown to improve outcomes in diabetics undergoing percutaneous coronary interventions. The purpose of the review is to examine potential mechanisms causing more restenosis in diabetics, the clinical outcomes of patients with diabetes after coronary interventions including stenting, the treatment alternatives of diabetic patients with diffuse coronary artery disease, including coronary bypass surgery, and current understanding of the benefit of adjunctive pharmacology on clinical outcomes after coronary interventions among diabetics.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Angina IV: Management
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures